Healthcare provider profile · identity verified

Bryan Joel Berman, M.D.

Family Practice · HIGHLAND HEIGHTS, KY · NPI 1902148422

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	537	155
Rosuvastatin Calcium	Rosuvastatin Calcium	487	145
Lisinopril	Lisinopril	415	115
Gabapentin	Gabapentin	357	57
Amlodipine Besylate	Amlodipine Besylate	293	86
Hydrochlorothiazide	Hydrochlorothiazide	289	81
Omeprazole	Omeprazole	265	77
Levothyroxine Sodium	Levothyroxine Sodium	264	73
Losartan Potassium	Losartan Potassium	254	71
Metoprolol Succinate	Metoprolol Succinate	201	57
Pantoprazole Sodium	Pantoprazole Sodium	199	57
Tamsulosin Hcl	Tamsulosin Hcl	179	59
Metformin Hcl Er	Metformin Hcl	161	51
Fluticasone Propionate	Fluticasone Propionate	151	65
Simvastatin	Simvastatin	144	41
Escitalopram Oxalate	Escitalopram Oxalate	136	47
Lorazepam	Lorazepam	136	34
Metformin Hcl	Metformin Hcl	129	36
Zolpidem Tartrate	Zolpidem Tartrate	127	17
Allopurinol	Allopurinol	126	37
Pravastatin Sodium	Pravastatin Sodium	114	32
Carvedilol	Carvedilol	110	33
Metoprolol Tartrate	Metoprolol Tartrate	108	28
Furosemide	Furosemide	106	40
Albuterol Sulfate Hfa	Albuterol Sulfate	104	40
Alprazolam	Alprazolam	103	13
Eliquis	Apixaban	102	33
Meloxicam	Meloxicam	102	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	100	26
Trazodone Hcl	Trazodone Hcl	100	33
Diclofenac Sodium	Diclofenac Sodium	89	30
Jardiance	Empagliflozin	88	24
Glimepiride	Glimepiride	87	24
Sertraline Hcl	Sertraline Hcl	81	26
Clopidogrel	Clopidogrel Bisulfate	80	21
Pioglitazone Hcl	Pioglitazone Hcl	80	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	21
Montelukast Sodium	Montelukast Sodium	75	24
Venlafaxine Hcl Er	Venlafaxine Hcl	69	16
Tramadol Hcl	Tramadol Hcl	67	18
Citalopram Hbr	Citalopram Hydrobromide	66	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	19
Duloxetine Hcl	Duloxetine Hcl	61	17
Alendronate Sodium	Alendronate Sodium	60	17
Tizanidine Hcl	Tizanidine Hcl	58	15
Valsartan	Valsartan	58	15
Farxiga	Dapagliflozin Propanediol	54	15
Fluoxetine Hcl	Fluoxetine Hcl	53	12
Prednisone	Prednisone	53	40
Potassium Chloride	Potassium Chloride	52	17
Bupropion Xl	Bupropion Hcl	51	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	14
Buspirone Hcl	Buspirone Hcl	46	13
Clonazepam	Clonazepam	46	12
Celecoxib	Celecoxib	45	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	14
Finasteride	Finasteride	42	15
Synthroid	Levothyroxine Sodium	40	12
Ezetimibe	Ezetimibe	39	14
Clonidine Hcl	Clonidine Hcl	35	13
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Spironolactone	Spironolactone	35	11
Xarelto	Rivaroxaban	35	11
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Glipizide	Glipizide	34	suppressed
Mounjaro	Tirzepatide	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	11
Ozempic	Semaglutide	33	11
Azelastine Hcl	Azelastine Hcl	32	14
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Famotidine	Famotidine	29	suppressed
Promethazine Hcl	Promethazine Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Myrbetriq	Mirabegron	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Atenolol	Atenolol	23	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Linzess	Linaclotide	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Cefdinir	Cefdinir	21	18
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Baclofen	Baclofen	18	suppressed
Temazepam	Temazepam	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Naproxen	Naproxen	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error